These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study. File TM, Mandell LA, Tillotson G, Kostov K, Georgiev O. J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866 [Abstract] [Full Text] [Related]
12. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability. Lode H, File TM, Mandell L, Ball P, Pypstra R, Thomas M, 185 Gemifloxacin Study Group. Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883 [Abstract] [Full Text] [Related]
13. Role of gemifloxacin in community-acquired pneumonia. Tillotson GS. Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107 [Abstract] [Full Text] [Related]
14. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Maimon N, Nopmaneejumruslers C, Marras TK. Eur Respir J; 2008 May; 31(5):1068-76. PubMed ID: 18216053 [Abstract] [Full Text] [Related]
16. Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials. An MM, Zou Z, Shen H, Gao PH, Cao YB, Jiang YY. Int J Antimicrob Agents; 2010 Jul; 36(1):58-65. PubMed ID: 20400271 [Abstract] [Full Text] [Related]
17. Gemifloxacin for community-acquired pneumonia. Lode HM, Schmidt-Ionas M, Stahlmann R. Expert Opin Investig Drugs; 2008 May; 17(5):779-86. PubMed ID: 18447602 [Abstract] [Full Text] [Related]
18. Gemifloxacin: a new fluoroquinolone. Blondeau JM, Missaghi B. Expert Opin Pharmacother; 2004 May; 5(5):1117-52. PubMed ID: 15155113 [Abstract] [Full Text] [Related]
20. Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections. Ball P, File TM, Twynholm M, Henkel T. Int J Antimicrob Agents; 2001 Jul; 18(1):19-27. PubMed ID: 11463522 [Abstract] [Full Text] [Related] Page: [Next] [New Search]